Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations

Antonio Passaro; Tony Mok; Solange Peters; Sanjay Popat; Myung‐Ju Ahn; Filippo de Marinis

doi:10.1016/j.jtho.2020.12.002

Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations

Authors: Antonio Passaro, Tony Mok, Solange Peters, Sanjay Popat, Myung‐Ju Ahn, Filippo de Marinis - Journal of Thoracic Oncology 2020 cited by 213

Recent Advances on the Role of EGFR Tyrosine Kinase Inhibitors in the Management of NSCLC With Uncommon, Non Exon 20 Insertions, EGFR Mutations | Litlas